| Financial Year |
March 31 2023 |
| Monetary Funds |
299,554,309.99 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
163,707,399.19 |
| Advances to Suppliers |
100,725,204.80 |
| Other Receivables |
3,007,960.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
252,278,062.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
363,890.51 |
| Total Current Assets |
901,119,828.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
16,236,605.88 |
| Fixed Assetes |
48,525,739.48 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
7,736,456.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,714,786.12 |
| Deferred Income Tax Assets |
21,005,551.12 |
| Other Non-Current Assets |
77,192,729.14 |
| Sub-Total of Non-Current Assets |
202,563,485.69 |
| Total Assets |
1,103,683,314.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
24,434,916.67 |
| Accounts Payable |
140,087,294.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,305,193.99 |
| Taxes Payable |
2,646,144.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,372,593.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,325,499.06 |
| Other Current Liabilities |
25,815,096.76 |
| Sub-Total of Current Liabilities |
410,564,405.49 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,057,709.35 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,869,857.27 |
| Total Liabilities |
433,434,262.76 |
| Paid-In Capital(Or Share Stock) |
146,421,932.00 |
| Capital Surplus |
329,157,734.74 |
| Surplus Reserve |
40,452,073.35 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
152,020,186.04 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
670,249,051.29 |
| Owner's Equity（Stockholder's Equity） |
670,249,051.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,103,683,314.05 |
